[Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 32, Issue 9, 2010, Pages 667-670

  Sun, Lei na ^a   Luan, Huan ling ^b   Zang, Feng lin ^b   Wang, Meng ^b   Dong, N ^b   Guo, Yan ^b   Sun, Bao cun ^b   Zhan, Zhong li ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; RAS PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASIAN; CODON; EXON; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MUTATION; ONCOGENE RAS; PATHOLOGY; PROTO ONCOGENE; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CODON; EXONS; FEMALE; GENES, ERBB-1; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; QUINAZOLINES; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 84862833236     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)